IDHIFA、恩西地平

Enasidenib

Another Name
IDHIFA、恩西地平
Indications
Enasidenib is suitable for Leukemia.
Reg No
09 L 1010/23
Inspection No
2272-23
dosage form:tablet
Specs:50mg*30 tablets
Indate:24 months
Date：2024-9-1 Views：1175
Drug Info

COMPOSITION:

Each tablet contains: Enasidenib……… 50mg

INDICATION:

LuciEna is an isocitrate dehydrogenase-2 inhibitor indicated for the treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with an isocitrate dehydrogenase-2 (IDH2) mutation.

DOSAGE AND USE:

The recommended dosage of LuciEna is 100 mg taken orally once daily with or without food until disease progression or unacceptable toxicity.

Tablet should be swallowed whole & not chewed or crushed.

STORAGE:

in a dry place and store at 20°C to 25°C.

MANUFACTURED AND MARKETED BY:

LUCIUS PHARMACEUTICALS(LAO) CO., LTD

No.26, Thongmang village, Xaythany district, Vientiane Capital, Laos

WARNING:

Keep medicine out of the reach of Children. Do not administered LuciEna in Pregnancy and Lactation patient treatment.

Enasidenib

Original article, if reprinted, please indicate the link to this article: https://lucius-pharmaceuticals.com/drug/enasidenib/

Related News